Skip to main content
Annals of Oncology logoLink to Annals of Oncology
. 2018 Apr 26;29(10):2152. doi: 10.1093/annonc/mdx805

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

W Shi, T Jiang, P Nuciforo, C Hatzis, E Holmes, N Harbeck, C Sotiriou, L Peña, S Loi, D D Rosa, S Chia, A Wardley, T Ueno, J Rossari, H Eidtmann, A Armour, M Piccart-Gebhart, D L Rimm, J Baselga, L Pusztai
PMCID: PMC6225898  PMID: 29701764

Ann Oncol 2017; 28: 128–135 (doi: 10.1093/annonc/mdw434)

In the original article, the following funding information was omitted: ‘This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748’. This has now been added.


Articles from Annals of Oncology are provided here courtesy of Oxford University Press

RESOURCES